Ryan Kole
Director Ejecutivo en Beyond Barriers Therapeutics, Inc. .
Perfil
Ryan Kole is currently the Chief Executive Officer at Beyond Barriers Therapeutics, Inc. and a Partner at Vcapital, Inc. He holds an MBA from The University of Chicago and an undergraduate degree from the University of Illinois at Urbana-Champaign.
Cargos activos de Ryan Kole
| Empresas | Cargo | Inicio |
|---|---|---|
Vcapital, Inc.
 Vcapital, Inc. Investment ManagersFinance Vcapital Inc (Vcapital) is a venture capital firm founded in 2000 by Len A Batterson and James Vaughan. The firm is headquartered in Chicago, Illinois. | Inversor de Capital Privado | 01/01/2016 |
Beyond Barriers Therapeutics, Inc.
 Beyond Barriers Therapeutics, Inc. BiotechnologyHealth Technology Beyond Barriers Therapeutics, Inc. is an American company that is developing a novel product to treat inflammation and cell death following traumatic brain injury (TBI). The company is based in Illinois, and the CEO of the company is Ryan Kole. The company aims to decrease the harmful effects of TBI by providing active therapy that could be administered intranasally immediately after impact to the head. The company's proprietary technology will lay the foundation for use of a novel, more effective delivery mechanism of small molecules to the brain. | Director Ejecutivo | - |
Formación de Ryan Kole.
| The University of Chicago | Masters Business Admin |
| University of Illinois At Urbana–Champaign | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Vcapital, Inc.
Vcapital, Inc. Investment ManagersFinance Vcapital Inc (Vcapital) is a venture capital firm founded in 2000 by Len A Batterson and James Vaughan. The firm is headquartered in Chicago, Illinois. | Finance |
Beyond Barriers Therapeutics, Inc.
Beyond Barriers Therapeutics, Inc. BiotechnologyHealth Technology Beyond Barriers Therapeutics, Inc. is an American company that is developing a novel product to treat inflammation and cell death following traumatic brain injury (TBI). The company is based in Illinois, and the CEO of the company is Ryan Kole. The company aims to decrease the harmful effects of TBI by providing active therapy that could be administered intranasally immediately after impact to the head. The company's proprietary technology will lay the foundation for use of a novel, more effective delivery mechanism of small molecules to the brain. | Health Technology |
- Bolsa de valores
- Insiders
- Ryan Kole